MAPS Public Benefit Corporation (“MAPS PBC”), a clinical-stage company dedicated to changing the way mental health conditions are treated, announced...
Historic filing marks first New Drug Application submission for any psychedelic-assisted therapy. The post Breaking News: MAPS Files New Drug Application...
Historic filing marks first New Drug Application submission for any psychedelic-assisted therapy. The post Breaking News: MAPS Files New Drug Application...
The Administrator of the Drug Enforcement Administration (DEA) has issued a temporary order to schedule six synthetic cannabinoids in schedule I under...
Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light Holland” or the “Company”), a company engaged in the production, growth...
What does it look like, where does it come from, and how strong is it? All this and more in our latest guide on Psilocybe Natalensis...
For those interested in ketamine treatment, there is a vast array of potential therapies designed to meet you where you’re at.
The paper provides a detailed review of the pharmacological actions of ibogaine and its metabolite noribogaine, highlighting their potential in treating...
Neuroscience research shows that the brain changes slowly through effortful learning, but can also rapidly rewire during transformative experiences, like...
Prolonged CBD use may alter brain connectivity in the hippocampus and amygdala, regions linked to memory and emotion, but its impact on mental health remains...